GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 18.06
+0.40 (2.27%)
At close: Sep 30, 2025
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 7.39 billion as of October 7, 2025. Its market cap has increased by 67.43% in one year.
Market Cap
7.39B
Enterprise Value
6.42B
Revenue
721.26M
Ranking
n/a
PE Ratio
71.69
Stock Price
18.06
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has decreased from 7.59B to 7.39B, a decrease of -2.62%. That is a compound annual growth rate of -0.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 7.39B | 40.72% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 476.78B |
| WuXi AppTec | 328.32B |
| Shenzhen Mindray Bio-Medical Electronics | 297.14B |
| Sichuan Biokin Pharmaceutical | 150.50B |
| Shanghai United Imaging Healthcare | 124.40B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
| Aier Eye Hospital Group | 114.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.26B |